6/14
12:09 pm
bcli
BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness Expectation [Yahoo! Finance]
Low
Report
BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness Expectation [Yahoo! Finance]
6/14
12:01 pm
bcli
BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness Expectation
Medium
Report
BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness Expectation
6/11
04:08 am
bcli
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
5/24
03:06 am
bcli
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
5/20
06:12 am
bcli
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn [Yahoo! Finance]
Medium
Report
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn [Yahoo! Finance]
5/20
06:00 am
bcli
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn
Medium
Report
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn
5/16
03:15 am
bcli
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/14
04:40 pm
bcli
BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/14/2023
07:05 am
bcli
brainstorm cell therapeutics inc.
BEAT
Report
-0.9%
brainstorm cell therapeutics inc.
8/14/2023
07:05 am
bcli
brainstorm cell therapeutics inc.
BEAT
Report
3.7%
brainstorm cell therapeutics inc.
6/4
06:06 am
bcli
Form 8-K BRAINSTORM CELL THERAPEU For: Jun 03
High
Report
Form 8-K BRAINSTORM CELL THERAPEU For: Jun 03
6/3
09:01 am
bcli
Form 4 BRAINSTORM CELL THERAPEU For: May 28 Filed by: Lebovits Chaim
Low
Report
Form 4 BRAINSTORM CELL THERAPEU For: May 28 Filed by: Lebovits Chaim
5/23
06:02 am
bcli
Form 4 BRAINSTORM CELL THERAPEU For: May 21 Filed by: Lebovits Chaim
Medium
Report
Form 4 BRAINSTORM CELL THERAPEU For: May 21 Filed by: Lebovits Chaim
5/14
05:01 pm
bcli
Form 10-Q BRAINSTORM CELL THERAPEU For: Mar 31
Medium
Report
Form 10-Q BRAINSTORM CELL THERAPEU For: Mar 31
5/14
07:53 am
bcli
Form 4 BRAINSTORM CELL THERAPEU For: May 10 Filed by: Lebovits Chaim
Medium
Report
Form 4 BRAINSTORM CELL THERAPEU For: May 10 Filed by: Lebovits Chaim
5/7
07:42 pm
bcli
Form 4 BRAINSTORM CELL THERAPEU For: May 07 Filed by: Lebovits Chaim
High
Report
Form 4 BRAINSTORM CELL THERAPEU For: May 07 Filed by: Lebovits Chaim
5/7
09:14 am
bcli
Form 4 BRAINSTORM CELL THERAPEU For: May 06 Filed by: Lebovits Chaim
Low
Report
Form 4 BRAINSTORM CELL THERAPEU For: May 06 Filed by: Lebovits Chaim
5/3
04:07 pm
bcli
Form 8-K BRAINSTORM CELL THERAPEU For: May 01
Low
Report
Form 8-K BRAINSTORM CELL THERAPEU For: May 01
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register